Stockscreener 앱 받기
100.98
2.38%
-2.18
전일 마감가:
$103.16
열려 있는:
$102.02
하루 거래량:
188.15K
Relative Volume:
0.23
시가총액:
$4.59B
수익:
$1.33B
순이익/손실:
$97.31M
주가수익비율:
49.70
EPS:
2.0317
순현금흐름:
$260.44M
1주 성능:
-2.08%
1개월 성능:
+16.28%
6개월 성능:
+60.23%
1년 성능:
+87.64%
1일 변동 폭
$100.59
$102.95
1주일 범위
$100.57
$103.56
52주 변동 폭
$47.31
$109.57
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
Compare HAE vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
100.94 | 4.69B | 1.33B | 97.31M | 260.44M | 2.0317 |
ABT
Abbott Laboratories
|
103.79 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.52 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.72 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.21 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.31 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | Needham | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 재확인 | Barrington Research | Outperform |
| 2025-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Q1 2027 Haemonetics Corp Earnings Call Transcript - GuruFocus
Haemonetics Stock Price Forecast. Should You Buy HAE? - StockInvest.us
HAE Maintained by Raymond James -- Price Target Raised to $125 - GuruFocus
Haemonetics Corporation (HAE) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Haemonetics Corporation (HAE) Peer Comparison – Compare with Others - Value Research
Haemonetics (HAE) Stock Looks Reasonable On Cash Flow But Rich On Earnings - simplywall.st
Haemonetics (HAE) Q1 2027 Earnings Call Transcript - AOL.ca
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
HAE Maintained by Baird -- Price Target Raised to $119.00 - GuruFocus
Haemonetics grows recurring revenues with plasm... - Pluang
Robert W. Baird Issues Positive Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics: Worth Speculating On This Recurring Medtech Plasma Model (NYSE:HAE) - Seeking Alpha
26,280 Shares in Haemonetics Corporation $HAE Acquired by Nierenberg Investment Management Company LLC - MarketBeat
Aurora Investment Counsel Acquires New Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics stock hits 52-week high at 106.64 USD By Investing.com - Investing.com South Africa
HAE Maintains by Barrington Research -- Price Target Raised to $118 - GuruFocus
HAEMONETICS CORP : BARRINGTON RESEARCH RAISES TARGET PRICE TO $118 FROM $95 - Bitget
Haemonetics stock hits 52-week high at 106.64 USD - Investing.com
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating - marketscreener.com
Haemonetics Shares Hit New 52-Week High: What's Happening? - Sahm
Is Haemonetics’ (HAE) ESOP Shelf Move Reframing Its Balance Between Growth Investment and Shareholder Dilution? - simplywall.st
Haemonetics Corp (HAE) Shares Surge 15.9% -- What GF Score of 85 Tells Investors - GuruFocus
HAE Maintained by BTIG -- Price Target Raised to $110 - GuruFocus
Haemonetics (HAE) Stock Climbs As Analysts Hike Price Targets - StocksToTrade
Form 8K Haemonetics Corp For: 18 August By Investing.com - Investing.com Australia
Haemonetics Jumps as Investors Cheer Raised Fiscal 2027 Outlook - Quiver Quantitative
HAE Looks 23.1% Overvalued on GF Value™ - GuruFocus
Haemonetics stock surges 16% on CSL Plasma supply deal By Investing.com - Investing.com Australia
Haemonetics stock surges 16% on CSL Plasma supply deal - Investing.com
HAE Looks 21.1% Overvalued on GF Value™ as Stock Surges to $104 - GuruFocus
Haemonetics (NYSE:HAE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Haemonetics (NYSE:HAE) Price Target Raised to $110.00 at BTIG Research - MarketBeat
Haemonetics Announces Non-Exclusive Supply Agreement with CSL Plasma for NexSys PCS Devices - Kalkine Media
HAE Looks 5.9% Overvalued on GF Value™ as Supply Deal with CSL P - GuruFocus
Why is Haemonetics stock surging today? - Investing.com
Why is Haemonetics stock surging today? By Investing.com - Investing.com Australia
Haemonetics announces non-exclusive supply agreement with CSL Plasma By Investing.com - Investing.com Australia
Haemonetics rises after supply deal with CSL - seekingalpha.com
Haemonetics announces non-exclusive supply agreement with CSL Plasma - Investing.com
Haemonetics signs non-exclusive U.S. supply deal with CSL Plasma for NexSys PCS devices - TradingView
Rice Hall James & Associates LLC Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Stock Could Be 49% Below Fair Value On Raised Guidance - Yahoo Finance
Haemonetics (HAE) Earnings Beat Puts Fair Value Back In Focus - Yahoo Finance
Haemonetics (NYSE:HAE) Shines in Quality Investing Screen - ChartMill
5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call - Yahoo Finance
John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Portfolio Impact - Yahoo Finance
John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Port - GuruFocus
HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up - Yahoo Finance
Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (NYSE:HAE) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.21%
0.10%
자본화:
|
볼륨(24시간):